Biolexis and Akston Biosciences announce encouraging results of thermostable 2nd Gen COVID-19 vaccine
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
Dr. Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.
Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals
Dasatinib Tablet is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive
Healthcare is timely and personal – and its delivery should be too
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry.
The product will be launched by NATCO's commercial partner Viatris.
The inspection was a Pre-Approval cum cGMP inspection and it covered 15 ANDAs
Subscribe To Our Newsletter & Stay Updated